-
Influencing factors of quality of life in asthma children
- ZHANG Boyuan, HOU Wei, DUAN Yina
-
2023, 31(12):
1359-1364.
DOI: 10.11852/zgetbjzz2023-0777
-
Asbtract
(
)
PDF (787KB)
(
)
-
References |
Related Articles |
Metrics
Objective To investigate the current status of quality of life in children with asthma and explore the impact of variables such as self-efficacy, psychological resilience, and asthma control level on the quality of life of these children, so as to provide insights for improving the quality of life of children with asthma and expanding asthma prevention and treatment strategies. Methods A total of 244 children aged 7 to 14 years with bronchial asthma who visited the Children's Asthma Clinic at the Second Affiliated Hospital of Xi'an Jiaotong University from February to December 2022 were selected as the study subjects. General information questionnaires, the General Self-Efficacy Scale (GSES), the Asthma Control Test (ACT), and the Pediatric Asthma Quality of Life Questionnaire (PAQLQ) were used for data collection, and statistical analysis was performed using SPSS 27.0. Results The total score of quality of life in children with asthma was 5.92±0.99, the score of self-efficacy was 2.69±0.55, and the scores for the interpersonal assistance dimension and positive cognition dimension of psychological resilience were 3.50±0.87 and 3.81± 0.89, the score on the asthma control level test was 21.87±3.67. The results of multiple stepwise linear regression analysis showed that whether combined withomalizumab(OMA) treatment, multiple comorbidities, and positive cognition were important influencing factors for the overall average score of PAQLQ (β = 0.18, 0.18, 0.17, P<0.05). Positive cognition and interpersonal assistance dimensions in psychological resilience, multiple comorbidities, and combined OMA treatment were influencing factors for the symptom score of quality of life in children with asthma (β=0.14, 0.13, 0.18, 0.15, P<0.05). Positive cognition, multiple comorbidities, and combined OMA treatment were important influencing factors for the activity limitation dimension of PAQLQ (β=0.20, 0.18, 0.17, P<0.05). Whether combined with OMA treatment, multiple comorbidities, and positive cognition were important influencing factors for the emotional function score of PAQLQ (β= 0.21, 0.18, 0.14, P<0.05). Conclusions The quality of life in asthmatic children in this study is at a moderate to high level. Having positive cognition, good interpersonal assistance, different types of diagnosis, and receiving OMA treatment all contribute to the quality of life of asthmatic children. Immunotherapy with biologic agents represented by OMA should be actively carried out in the clinic, and attention should also be paid to health education and psychological resilience development to enhance the quality of life of asthmatic children.